In its upcoming report, Medtronic (MDT) is predicted by Wall Street analysts to post quarterly earnings of $1.36 per share, reflecting an increase of 4.6% compared to the same period last year.

Hello and welcome to Modern CEO! I’m Stephanie Mehta, CEO and chief content officer of Mansueto Ventures. Each week this ...

Nanovis, a leading developer and provider of nano surface technology that improves the biologic fixation of orthopedic, spine ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Medtronic (MDT – Research Report), Biohaven Ltd. (BHVN – ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Medtronic (MDT – Research Report), with a price target of ...

At the University of Minnesota's heart lab, millions of dollars of tubing and wires and technology work to keep a living ...

Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

Medtronic is supporting the transition to renewable energy by sourcing electricity from a local wind farm just 30 minutes ...

The company will keep the systems on the market but is asking providers to check devices for visible cracks and return ...

In the closing of the recent trading day, Medtronic (MDT) stood at $91.69, denoting a +0.79% change from the preceding trading day.

Long-term plays are nothing new for Medtronic, which was founded as a medical device repair business in 1949 by Earl Bakken and Palmer Hermundslie. The company introduced the first battery ...